Many studies have shown that elevated expression or activity of transforming growth factor-beta (TGF-β) contributes to progressive human kidney diseases, and animal models have identified TGF-β as a key pathogenic driver of organ fibrosis, including renal tubulointerstitial fibrosis1,2. This evidence concerns the gene TGFB1 and kidney disorder.